Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label randomized trial of tolvaptan plus low-dose furosemide versus high-dose furosemide in hospitalized heart failure
TCTR20190805001Not yet recruiting
- Sponsor
- Thai Otsuka Pharmaceutical
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in heart failure (HF) comparing Tolvaptan plus low-dose furosemide with High-dose furosemide (2 arms). Planned start Aug 2019; status: not yet recruiting.
02
Drugs
tolvaptanfurosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on TCTR20190805001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190805001.